Rising Indian EMS industry driven by government support, steady demand, and potential growth, avoiding pitfalls of past tech ...

Rising Indian EMS industry driven by government support, steady demand, and potential growth, avoiding pitfalls of past tech ...

These two tech leaders have already delivered life-changing returns to their long-term shareholders, but it's not too late to ...

HII (HII), America’s largest military shipbuilder, and C3 AI (NYSE: AI), the Enterprise AI application software company, have recently announced a strategic partnership to expand digital technologies ...

A new study finds early humans ate tough grasses and tubers long before their teeth adapted, suggesting behavior, not biology, drove human evolution.

The company's customer wins this year suggest more revenue expansion to come. In fact, C3.ai forecasts fiscal 2026 sales to ...

C3.ai's CEO and founder, Tom Siebel, has announced his decision to step down once a new CEO is in place. C3.ai could go two different ways with its CEO search. 10 stocks we like better than C3.ai › C3 ...

Upgrade your portfolio! C3.ai is a strong buy with explosive growth, top-tier partnerships, and AI exposure at a discount.

M&A is back is in style again under President Donald Trump. That’s good news for investors in stocks such as C3.ai, Viking ...

Apellis Pharmaceuticals Inc. (NASDAQ:APLS) is one of the biotech stocks to buy according to Wall Street analysts.

Tempus AI offers a strong business model with AI-driven genomic data, resilient demand, and significant growth prospects.

Founded in 2009 by Thomas Siebel, C3.ai's core purpose has always been to deliver AI solutions to enterprises. Its value ...